down arrow

SMS Pharma.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE812G01025
  • NSEID: SMSPHARMA
  • BSEID: 532815
INR
204.10
5.9 (2.98%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 65.74 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

203.00205.05

52 Week

175.00398.00
Valuation
Technical
Day's Volume

CASH

65.74 k (-34.91%) Volume

Shareholding (Mar 2025)

FII

0.08%

Held by 7 FIIs

DII

2.43%

Held by 3 DIIs

Promoter

66.26%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor long term growth as Net Sales has grown by an annual rate of 13.23% and Operating profit at 10.22% over the last 5 years

 
2

Stock is technically in a Mildly Bearish range

3

37.6% of Promoter Shares are Pledged

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 1,728 Cr (Small Cap)

stock-summary
P/E

25.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.20%

stock-summary
Debt Equity

0.49

stock-summary
Return on Equity

10.53%

stock-summary
Price to Book

2.98

Revenue and Profits (1 Year):
Net Sales:
173 Cr
(Quarterly Results - Dec 2024)
Net Profit:
18 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.2%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-41.13%
0%
-41.13%
1 Year
-1.45%
0.19%
-1.26%
2 Years
176.97%
0.81%
177.78%
3 Years
89.77%
1.23%
91.0%
4 Years
38.7%
0.86%
39.56%
5 Years
497.66%
3.43%
501.09%

Latest dividend: 0.4000000000000001 per share ex-dividend date: Sep-23-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
13.23%
EBIT Growth (5y)
10.22%
EBIT to Interest (avg)
4.37
Debt to EBITDA (avg)
2.88
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.80
Tax Ratio
25.94%
Dividend Payout Ratio
4.08%
Pledged Shares
37.60%
Institutional Holding
2.51%
ROCE (avg)
10.67%
ROE (avg)
9.18%
Valuation key factors
Factor
Value
P/E Ratio
25
Industry P/E
33
Price to Book Value
2.98
EV to EBIT
19.90
EV to EBITDA
14.82
EV to Capital Employed
2.33
EV to Sales
2.50
PEG Ratio
0.36
Dividend Yield
0.20%
ROCE (Latest)
11.27%
ROE (Latest)
10.53%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

37.5976

Mutual Funds

Held by 3 Schemes (2.43%)

FIIs

Held by 7 FIIs (0.08%)

Promoter with highest holding

Ramesh Babu Potluri (20.48%)

Highest Public shareholder

Quant Mutual Fund - Quant Small Cap Fund (2.43%)

Individual Investors Holdings

26.35%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -11.89% vs 19.64% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 29.36% vs -14.44% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "173.35",
          "val2": "196.75",
          "chgp": "-11.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "33.21",
          "val2": "31.47",
          "chgp": "5.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.20",
          "val2": "4.61",
          "chgp": "-8.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "18.24",
          "val2": "14.10",
          "chgp": "29.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "19.16%",
          "val2": "15.99%",
          "chgp": "3.17%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 19.61% vs 34.92% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 45.14% vs 242.56% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "361.20",
          "val2": "301.98",
          "chgp": "19.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "64.98",
          "val2": "54.00",
          "chgp": "20.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "9.27",
          "val2": "11.89",
          "chgp": "-22.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "30.58",
          "val2": "21.07",
          "chgp": "45.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "17.99%",
          "val2": "17.88%",
          "chgp": "0.11%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 15.34% vs 24.38% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 49.98% vs 395.37% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "534.55",
          "val2": "463.46",
          "chgp": "15.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "98.19",
          "val2": "83.00",
          "chgp": "18.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "13.47",
          "val2": "17.84",
          "chgp": "-24.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "48.82",
          "val2": "32.55",
          "chgp": "49.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "18.37%",
          "val2": "17.91%",
          "chgp": "0.46%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 35.86% vs 0.42% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 805.81% vs -111.35% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "709.26",
          "val2": "522.05",
          "chgp": "35.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "116.62",
          "val2": "54.48",
          "chgp": "114.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "23.46",
          "val2": "21.91",
          "chgp": "7.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "49.83",
          "val2": "-7.06",
          "chgp": "805.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "16.44%",
          "val2": "10.44%",
          "chgp": "6.00%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
173.35
196.75
-11.89%
Operating Profit (PBDIT) excl Other Income
33.21
31.47
5.53%
Interest
4.20
4.61
-8.89%
Exceptional Items
0.00
0.00
Consolidate Net Profit
18.24
14.10
29.36%
Operating Profit Margin (Excl OI)
19.16%
15.99%
3.17%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -11.89% vs 19.64% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is 29.36% vs -14.44% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
361.20
301.98
19.61%
Operating Profit (PBDIT) excl Other Income
64.98
54.00
20.33%
Interest
9.27
11.89
-22.04%
Exceptional Items
0.00
0.00
Consolidate Net Profit
30.58
21.07
45.14%
Operating Profit Margin (Excl OI)
17.99%
17.88%
0.11%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 19.61% vs 34.92% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 45.14% vs 242.56% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
534.55
463.46
15.34%
Operating Profit (PBDIT) excl Other Income
98.19
83.00
18.30%
Interest
13.47
17.84
-24.50%
Exceptional Items
0.00
0.00
Consolidate Net Profit
48.82
32.55
49.98%
Operating Profit Margin (Excl OI)
18.37%
17.91%
0.46%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 15.34% vs 24.38% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 49.98% vs 395.37% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
709.26
522.05
35.86%
Operating Profit (PBDIT) excl Other Income
116.62
54.48
114.06%
Interest
23.46
21.91
7.07%
Exceptional Items
0.00
0.00
Consolidate Net Profit
49.83
-7.06
805.81%
Operating Profit Margin (Excl OI)
16.44%
10.44%
6.00%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 35.86% vs 0.42% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 805.81% vs -111.35% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About SMS Pharmaceuticals Ltd stock-summary
stock-summary
SMS Pharmaceuticals Ltd
Small Cap
Pharmaceuticals & Drugs
SMS Pharmaceuticals Limited was incorporated in December, 1987. The company is engaged in the business of manufacturing of Active Pharma Ingredients and their intermediates. Apart from R &D Center at Gagillapur, Hyderabad, the company is having manufacturing facilities at Bachupally, Hyderabad and also at Kandivalasa Village in Vijayanagaram District of Andhra Pradesh. Its business activity is a single primary business segment of "Bulk Drugs".
Company Coordinates stock-summary
Company Details
19 III Rd 71 Opp Bharatividya, Bhavan Public Sch Jubilee Hill Hyderabad Telangana : 500096
stock-summary
Tel: 91-40-66288888
stock-summary
http://www.smspharma.com
stock-summary
info@smspharma.com
Registrar Details
Aarthi Consultants Pvt Ltd, 1-2-285 , Domalaguda, Hyderabad
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."